InnovAge (NASDAQ:INNV) Posts Quarterly Earnings Results

InnovAge (NASDAQ:INNVGet Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.10) earnings per share for the quarter, Zacks reports. InnovAge had a negative return on equity of 5.68% and a negative net margin of 2.03%. InnovAge updated its FY 2025 guidance to EPS.

InnovAge Stock Down 8.9 %

INNV stock opened at $3.36 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.21 and a quick ratio of 1.21. The company’s 50 day simple moving average is $4.04 and its 200-day simple moving average is $5.23. InnovAge has a 12 month low of $3.12 and a 12 month high of $6.69. The firm has a market capitalization of $455.15 million, a PE ratio of -28.00 and a beta of 0.37.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on INNV. JPMorgan Chase & Co. restated an “underweight” rating and set a $5.00 target price on shares of InnovAge in a research report on Tuesday, December 17th. KeyCorp began coverage on InnovAge in a research note on Friday, October 11th. They issued a “sector weight” rating for the company.

View Our Latest Analysis on InnovAge

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Read More

Earnings History for InnovAge (NASDAQ:INNV)

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.